These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 16709615

  • 1. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
    Liao L, Dearth RK, Zhou S, Britton OL, Lee AV, Xu J.
    Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
    [Abstract] [Full Text] [Related]

  • 2. Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression.
    Liao L, Chen X, Wang S, Parlow AF, Xu J.
    Mol Cell Biol; 2008 Apr; 28(7):2460-9. PubMed ID: 18212051
    [Abstract] [Full Text] [Related]

  • 3. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E, Velasco B, Barrios R, Sanchez-Franco F.
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [Abstract] [Full Text] [Related]

  • 4. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG.
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I.
    Lemmey AB, Glassford J, Flick-Smith HC, Holly JM, Pell JM.
    J Endocrinol; 1997 Aug; 154(2):319-28. PubMed ID: 9291843
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
    Wilson ME.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
    [Abstract] [Full Text] [Related]

  • 8. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 9. Dose-response effects of a new growth hormone receptor antagonist (B2036-PEG) on circulating, hepatic and renal expression of the growth hormone/insulin-like growth factor system in adult mice.
    van Neck JW, Dits NF, Cingel V, Hoppenbrouwers IA, Drop SL, Flyvbjerg A.
    J Endocrinol; 2000 Nov; 167(2):295-303. PubMed ID: 11054644
    [Abstract] [Full Text] [Related]

  • 10. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
    Domené HM, Scaglia PA, Jasper HG.
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
    [Abstract] [Full Text] [Related]

  • 11. Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice.
    Cingel-Ristic V, Van Neck JW, Frystyk J, Drop SL, Flyvbjerg A.
    Endocrinology; 2004 Sep; 145(9):4401-7. PubMed ID: 15166120
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.
    Ward WE, Donovan SM, Atkinson SA.
    Pediatr Res; 1998 Aug; 44(2):215-21. PubMed ID: 9702917
    [Abstract] [Full Text] [Related]

  • 13. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C, Clemmons DR, D'Ercole AJ.
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [Abstract] [Full Text] [Related]

  • 15. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE, Tapanainen P, Rosenfeld RG.
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [Abstract] [Full Text] [Related]

  • 16. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent.
    Flyvbjerg A, Bennett WF, Rasch R, van Neck JW, Groffen CA, Kopchick JJ, Scarlett JA.
    Kidney Int; 1999 Dec; 56(6):2048-54. PubMed ID: 10594780
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 Dec; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 18. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
    Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
    [Abstract] [Full Text] [Related]

  • 19. Testosterone effect on growth and growth mediators of the GH-IGF-I axis in the liver and epiphyseal growth plate of juvenile rats.
    Zung A, Phillip M, Chalew SA, Palese T, Kowarski AA, Zadik Z.
    J Mol Endocrinol; 1999 Oct; 23(2):209-21. PubMed ID: 10514558
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats.
    Domené H, Krishnamurthi K, Eshet R, Gilad I, Laron Z, Koch I, Stannard B, Cassorla F, Roberts CT, LeRoith D.
    Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.